Granite Point Capital logo

Granite Point Capital

North America, Massachusetts, United States, Boston

Description

Granite Point Capital is a hedge fund. They have closed-end investment office in Boston, MA. Jeffrey Barnett, the chief operating officer

Investor Profile

Granite Point Capital has made 12 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series Unknown (17%)
  • Series C (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Internet
  • Biopharma
  • E-commerce
  • Marketplace
  • Software
  • Pharmaceutical
  • Consumer Goods
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Granite Point Capital frequently co-invest with?

Jump Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
Altium Capital
North America, New York, United States, New York
Co-Investments: 2
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 3
Amzak Health Investors
North America, New York, United States, New York
Co-Investments: 2
LV
North America, New York, United States, New York
Co-Investments: 3
CAM Capital
North America, New York, United States, New York
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 3
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Granite Point Capital often collaborate with?

EB
North America, California, United States, Palo Alto
Shared Deals: 1
JH
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
LJ
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Granite Point Capital?

Cerebral Therapeutics

Aurora, Colorado, United States

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CJun 28, 2022
Amount Raised: $40,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Teikametrics

Boston, Massachusetts, United States

Teikametrics is an e-commerce optimization platform designed for retailers on online marketplaces.

E-CommerceInternetMarketplaceSoftware
Series BJul 15, 2021
Amount Raised: $40,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BApr 12, 2021
Amount Raised: $96,000,000
Teikametrics

Boston, Massachusetts, United States

Teikametrics is an e-commerce optimization platform designed for retailers on online marketplaces.

E-CommerceInternetMarketplaceSoftware
Series UnknownFeb 20, 2020
Amount Raised: $15,000,000
Cerebral Therapeutics

Aurora, Colorado, United States

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJan 6, 2020
Amount Raised: $35,000,000
Teikametrics

Boston, Massachusetts, United States

Teikametrics is an e-commerce optimization platform designed for retailers on online marketplaces.

E-CommerceInternetMarketplaceSoftware
Series AOct 25, 2018
Amount Raised: $10,000,000
Cerebral Therapeutics

Aurora, Colorado, United States

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJun 20, 2018
Amount Raised: $3,000,000
DOTS

Natick, Massachusetts, United States

DOTS (Detection On The Spot) is creating a revolutionary protein detection platform to improve the quality of life for millions of people.

Consumer GoodsHealth CarePersonal HealthWellness
Series UnknownFeb 20, 2018
Engage Therapeutics

Summit, New Jersey, United States

Engage Therapeutics is a clinical stage pharmaceutical company with a deep-seated passion in epilepsy.

BiopharmaBiotechnologyTherapeutics
Series ASep 27, 2017
Amount Raised: $23,600,000